Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Francis Willard Sarena. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Francis Willard Sarena reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:ETNB / 89bio, Inc. Chief Operating Officer 0
US:APGN / Apexigen Inc President and COO 0
Chief Strategy Officer 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Francis Willard Sarena. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Francis Willard Sarena conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2025-10-30 2025-10-30 4 ETNB 89bio, Inc.
Common Stock
U - Other -75,310 0 -100.00
2025-08-05 2025-08-05 4 ETNB 89bio, Inc.
Common Stock
F - Taxes -2,979 74,231 -3.86 9.69 -28,867 719,298
2025-08-05 2025-08-01 4 ETNB 89bio, Inc.
Common Stock
F - Taxes -3,206 77,210 -3.99 9.16 -29,367 707,244
2025-02-04 2025-02-01 4 ETNB 89bio, Inc.
Common Stock
A - Award 53,750 78,750 215.00
2024-08-07 2024-08-05 4 ETNB 89bio, Inc.
Common Stock
A - Award 25,000 25,000
2023-08-25 2023-08-23 4 APGN Apexigen, Inc.
Common Stock
D - Sale to Issuer -124,296 0 -100.00
2023-08-25 2023-08-23 4 APGN Apexigen, Inc.
Common Stock
F - Taxes -31,123 124,296 -20.03 0.39 -11,985 47,866
2023-06-23 2023-06-15 4 APGN Apexigen, Inc.
Common Stock
F - Taxes -6,917 155,419 -4.26 0.49 -3,397 76,326
2023-05-25 2023-05-23 4 APGN Apexigen, Inc.
Common Stock
F - Taxes -20,748 162,336 -11.33 0.40 -8,299 64,934
2023-05-25 2023-05-23 4 APGN Apexigen, Inc.
Common Stock
A - Award 150,000 183,084 453.39
2022-12-19 2022-12-15 4 APGN Apexigen, Inc.
Common Stock
F - Taxes -6,916 33,084 -17.29 1.06 -7,331 35,069
2022-10-11 2022-10-07 4 APGN Apexigen, Inc.
Common Stock
A - Award 40,000 40,000
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -90,000 0 -100.00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -90,000 0 -100.00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -58,000 0 -100.00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -45,000 0 -100.00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -75,000 0 -100.00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -25,521 0 -100.00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -3,209 0 -100.00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -12,063 0 -100.00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -9,142 0 -100.00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
D - Sale to Issuer -4,747 0 -100.00
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
D - Sale to Issuer -795 0 -100.00 38.00 -30,210
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
D - Sale to Issuer -795 0 -100.00 38.00 -30,210
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
D - Sale to Issuer -795 0 -100.00 38.00 -30,210
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
D - Sale to Issuer -169,468 0 -100.00 38.00 -6,439,784
2021-04-19 2021-04-16 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
A - Award 66,000 169,468 63.79
2021-04-19 2021-04-06 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
G - Gift -14,174 103,468 -12.05
2021-04-19 2021-04-05 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
G - Gift -2,460 117,642 -2.05
2021-04-19 2021-04-01 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
G - Gift -1,440 120,102 -1.18
2021-04-19 2021-04-01 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
G - Gift 795 795
2021-04-19 2021-04-01 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
G - Gift 795 795
2021-04-19 2021-04-01 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
G - Gift 795 795
2021-04-19 2021-04-01 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
G - Gift -2,385 121,542 -1.92
2021-03-02 2021-02-26 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,158 123,433 -0.93 22.23 -25,742 2,743,916
2021-02-26 2021-02-25 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,653 124,591 -1.31 23.08 -38,151 2,875,560
2021-02-26 2021-02-24 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
F - Taxes -5,100 126,244 -3.88 25.71 -131,121 3,245,733
2020-12-15 2020-12-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Performance-Based Restricted Common Stock
M - Exercise -22,000 0 -100.00
2020-12-15 2020-12-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
F - Taxes -11,583 126,427 -8.39 16.14 -186,950 2,040,532
2020-12-15 2020-12-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
M - Exercise 22,000 138,010 18.96
2020-11-13 2020-11-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Performance-Based Restricted Common Stock
M - Exercise -22,000 22,000 -50.00
2020-11-13 2020-11-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
F - Taxes -11,001 116,010 -8.66 18.00 -198,018 2,088,180
2020-11-13 2020-11-11 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
M - Exercise 22,000 127,011 20.95
2020-02-26 2020-02-26 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,304 105,011 -1.23 4.83 -6,298 507,203
2020-02-26 2020-02-25 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,863 106,315 -1.72 4.87 -9,073 517,754
2020-02-26 2020-02-24 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 90,000 90,000
2020-02-26 2020-02-24 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
A - Award 90,000 90,000
2020-02-26 2020-02-24 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
A - Award 15,000 108,178 16.10
2020-02-26 2020-02-24 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
A - Award 15,000 108,178 16.10
2020-02-06 2020-02-05 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
F - Taxes -4,070 78,178 -4.95 5.13 -20,879 401,053
2019-09-04 2019-09-01 4 FPRX FIVE PRIME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,811 82,248 -3.30 5.43 -15,264 446,607
2019-06-26 2019-06-24 4 FPRX FIVE PRIME THERAPEUTICS INC
Performance-Based Restricted Common Stock
A - Award 44,000 44,000
2019-02-27 2019-02-26 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
F - Taxes -1,194 82,955 -1.42 11.95 -14,268 991,312
2019-02-27 2019-02-25 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
A - Award 58,000 58,000
2019-02-27 2019-02-25 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
A - Award 10,000 84,149 13.49
2019-02-07 2019-02-05 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
F - Taxes -2,996 74,149 -3.88 11.43 -34,244 847,523
2018-10-02 2018-09-28 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
F - Taxes -954 77,145 -1.22 13.92 -13,280 1,073,858
2018-10-02 2018-09-28 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
A - Award 1,923 78,099 2.52
2018-09-05 2018-09-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
F - Taxes -2,810 76,177 -3.56 14.00 -39,340 1,066,478
2018-02-28 2018-02-26 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
A - Award 45,000 45,000
2018-02-28 2018-02-26 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
A - Award 7,000 78,987 9.72
2017-09-07 2017-03-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
F - Taxes -3,131 71,987 -4.17 34.34 -107,519 2,472,034
2017-03-03 2017-03-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
F - Taxes -19,784 75,118 -20.85 44.77 -885,730 3,363,033
2017-02-09 2017-02-07 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
A - Award 45,000 45,000
2017-02-09 2017-02-07 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
A - Award 5,768 94,902 6.47
2017-02-09 2017-02-07 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
A - Award 10,310 89,134 13.08
2017-01-18 2017-01-18 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -3,636 9,142 -28.46
2017-01-18 2017-01-18 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -3,636 78,824 -4.41 47.39 -172,310 3,735,469
2017-01-18 2017-01-18 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 3,636 82,460 4.61 5.54 20,143 456,828
2017-01-05 2017-01-03 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
F - Taxes -2,442 78,824 -3.00 48.60 -118,681 3,830,846
2016-11-30 2016-11-28 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -1,710 12,778 -11.80
2016-11-30 2016-11-28 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -1,710 81,266 -2.06 60.14 -102,839 4,887,337
2016-11-30 2016-11-28 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 1,710 82,976 2.10 5.54 9,473 459,687
2016-11-28 2016-11-25 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -10,264 14,488 -41.47
2016-11-28 2016-11-25 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -10,925 0 -100.00
2016-11-28 2016-11-25 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -21,189 81,266 -20.68 60.48 -1,281,511 4,914,968
2016-11-28 2016-11-25 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 10,264 102,455 11.13 5.54 56,863 567,601
2016-11-28 2016-11-25 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 10,925 92,191 13.44 6.89 75,273 635,196
2016-11-28 2016-11-23 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -13,465 10,925 -55.21
2016-11-28 2016-11-23 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -13,465 81,266 -14.21 60.23 -810,997 4,894,651
2016-11-28 2016-11-23 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 13,465 94,731 16.57 6.89 92,774 652,697
2016-09-12 2016-09-08 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
A - Award 35,000 35,000
2016-09-12 2016-09-08 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
A - Award 7,000 81,266 9.43
2016-09-01 2016-09-01 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
F - Taxes -19,568 74,266 -20.85 44.74 -875,472 3,322,661
2016-08-29 2016-08-25 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
A - Award 60,000 60,000
2016-08-29 2016-08-25 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
A - Award 10,000 93,834 11.93
2016-03-31 2016-03-30 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -5,550 4,747 -53.90
2016-03-31 2016-03-30 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -5,550 83,834 -6.21 40.01 -222,056 3,354,198
2016-03-31 2016-03-30 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 5,550 89,384 6.62 8.49 47,120 758,870
2016-03-31 2016-03-29 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -3,524 10,297 -25.50
2016-03-31 2016-03-29 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -926 0 -100.00
2016-03-31 2016-03-29 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -4,450 83,834 -5.04 40.00 -178,000 3,353,360
2016-03-31 2016-03-29 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 4,450 88,284 5.31 8.49 37,780 749,531
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -1,513 926 -62.03
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -7,768 24,752 -23.89
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -7,449 12,063 -38.18
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -3,791 3,209 -54.16
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
M - Exercise -9,479 25,521 -27.08
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -1,513 83,570 -1.78 35.00 -52,955 2,924,950
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 1,513 85,083 1.81 8.49 12,845 722,355
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -7,768 83,570 -8.50 34.73 -269,783 2,902,386
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 7,768 91,338 9.30 5.54 43,035 506,013
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -7,449 83,570 -8.18 35.11 -261,534 2,934,143
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 7,449 91,019 8.91 7.26 54,080 660,798
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -3,791 83,570 -4.34 35.31 -133,860 2,950,857
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 3,791 87,361 4.54 10.77 40,829 940,878
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -2,584 83,570 -3.00 36.13 -93,360 3,019,384
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
S - Sale X -6,895 86,154 -7.41 35.55 -245,117 3,062,775
2016-01-29 2016-01-27 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
M - Exercise 9,479 93,049 11.34 11.14 105,596 1,036,566
2015-08-21 2015-08-20 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
A - Award 75,000 83,570 875.15
2015-08-19 2015-08-17 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
A - Award 75,000 75,000
2015-05-04 2015-04-30 4 FPRX FIVE PRIME THERAPEUTICS INC
Common Stock
A - Award 6,110 8,570 248.37
2014-08-26 2014-08-22 4 FPRX FIVE PRIME THERAPEUTICS INC
Employee Stock Option (right to buy)
A - Award 35,000 35,000
2013-11-07 2013-11-05 4 FPRX FIVE PRIME THERAPEUTICS INC
Stock Option (right to buy)
A - Award 7,000 7,000
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)